We are live on ! Find out more
BCP

Berylson Capital Partners Portfolio holdings

AUM $41.2M
1-Year Est. Return 0.19%
This Fund
S&P 500
This Quarter Est. Return
-7.75%
1 Year Est. Return
-0.19%
3 Year Est. Return
-57.73%
5 Year Est. Return
-34.23%
10 Year Est. Return
AUM
$34.3M
AUM Growth
-$26.2M
Cap. Flow
-$24.4M
Cap. Flow %
-71.21%
Top 10 Hldgs %
76.64%
Holding
29
New
6
Increased
3
Reduced
6
Closed
10

Top Sells

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$5.27M
2
TOST icon
Toast
TOST
+$4.1M
3
WRBY icon
Warby Parker
WRBY
+$3.94M
4
BILI icon
Bilibili
BILI
+$3.49M
5
LFG
Archaea Energy Inc.
LFG
+$3.06M

Sector Composition

Rank Sector Weight
1 Technology 59.85%
2 Consumer Discretionary 19.21%
3 Healthcare 11.33%
4 Communication Services 9.59%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIVN icon
26
Rivian
RIVN
$22.3B
-27,137
Closed -$893K
Z icon
27
Zillow
Z
$7.65B
-85,400
Closed -$2.44M
FTCH
28
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-393,000
Closed -$2.93M
LFG
29
DELISTED
Archaea Energy Inc.
LFG
-169,917
Closed -$3.06M

Similar funds

Berylson Capital Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Berylson Capital Partners held 29 positions worth $34.3M, down 43% from $60.5M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Berylson Capital Partners withdrew a net $24.4M in Q4 2022, closing 10 positions and reducing 6 holdings. Its most notable exit was Ascendis Pharma A/S, an estimated $5.27M position sold in full.

By sector, the portfolio is most concentrated in Technology at 60% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Berylson Capital Partners opened a new position in BILL Holdings worth $3.29M.

  • Berylson Capital Partners's largest Q4 2022 buy was BILL Holdings: 30,200 shares worth $3.29M.
  • Berylson Capital Partners added most to People Inc in Q4 2022, an estimated $2.7M increase.
  • Berylson Capital Partners's biggest Q4 2022 reduction was Toast, cutting an estimated $4.1M.
  • Berylson Capital Partners fully exited Ascendis Pharma A/S in Q4 2022, selling an estimated $5.27M.
  • Berylson Capital Partners's ten largest holdings make up 77% of its $34.3M portfolio in Q4 2022.
  • Berylson Capital Partners opened 6 new positions and closed 10 in Q4 2022.
  • Berylson Capital Partners's portfolio value fell 43% quarter-over-quarter to $34.3M.

Based on Berylson Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.